Cefdinir

Product NDC
0904-7563
11-digit product format
009047563
Labeler code
0904
Product ID
0904-7563_a0934baf-4745-4546-a63a-d4a660a188b3
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cefdinir
Dosage form
CAPSULE
Route
ORAL
Labeler
Major Pharmaceuticals
Application
ANDA210220
Marketing category
ANDA
Marketing start
2025-10-27
Substance
CEFDINIR
Active strength
300 mg/1
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A210220-001CEFDINIRCEFDINIR300MGCAPSULE / ORALAB2021-02-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A210220-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-1979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-191e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-198072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-195c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-195d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-194b0b4de00fa7…
2022-03-09 01:35 UTC2022-03A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-1987673890dc5c…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-196a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-191c564ffb4f44…
2023-12-20 04:57 UTC2023-12A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-199b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-193f0d92c62455…
2023-05-13 08:27 UTC2023-05A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19053a50430f4f…
2023-01-26 05:58 UTC2023-01A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-193bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-193a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A210220-001CEFDINIR300MGCAPSULE / ORALAB2021-02-19a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A210220-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210220-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A210220-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210220-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210220-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210220-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210220-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210220-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210220-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210220-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210220-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210220-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210220-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210220-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210220-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A210220-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A210220-001AB14b0b4de00fa7…
2022-03-09 01:35 UTC2022-03A210220-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A210220-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A210220-001AB187673890dc5c…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A210220-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A210220-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A210220-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A210220-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A210220-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A210220-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A210220-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A210220-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A210220-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A210220-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A210220-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A210220-001AB1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A210220-001AB1cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A210220-001AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Cefdinir
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEFDINIR300 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
CI0FAO63WCInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
200346Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
a0934baf-4745-4546-a63a-d4a660a188b3Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d3e72f63-2c41-955f-f4ce-e90c6403e67cProduct name220210729
e8e66e64-d220-99cb-44eb-0f32dc8cbda1Product name220210729

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0904-7563-04Cefdinir10 in 1 BLISTER PACKCAPSULE101
0904-7563-04Cefdinir3 in 1 CARTONCAPSULE31

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0904-7563-04EA - Each0904-75635538ccb6-0489-4038-870c-437a7723612b12025-11-13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 15 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefdinirCEFDINIRNorthwind Health Company, LLC1d0d50ba-8c2b-855c-e063-6394a90a5c7d2026-07-09Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRProficient Rx LP63d2f931-6896-47e5-905e-4f812d6cb1052026-06-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRREMEDYREPACK INC.a8029f7c-6353-46db-8c8c-c86a9485a14f2026-05-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRNuCare Pharmaceuticals,Inc.c23af6af-a97b-b98d-e053-2995a90ae7802026-03-13Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRMajor Pharmaceuticalsa0934baf-4745-4546-a63a-d4a660a188b32025-10-23Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
ndc (product): 0904-7563
CefdinirCEFDINIRBryant Ranch Prepack63aa0304-574f-4d37-9fb4-26ffb058fbec2025-08-20Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRBryant Ranch Prepackd5fd32d8-66de-4a9f-9b83-88b190a903772025-08-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRAscend Laboratories, LLC18888955-4db3-4d0d-939f-eaaa5f2e0dc42025-06-25Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRPreferred Pharmaceuticals Inc.c5142dca-4fb8-467d-910a-e8228e694c942025-02-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRRedpharm Drug, Inc.f3d228c8-bde9-ffcf-e053-2a95a90aa5c42025-01-23Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CEFDINIRCEFDINIRDirectRxd70b9e1f-908f-b570-e053-2995a90af0982025-01-21Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRNuCare Pharmaceuticals,Inc.c974d975-8616-3551-e053-2995a90a65f32025-01-14Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRAmerican Health Packagingc493e78b-afa3-4f74-8305-75e5f3817df02024-06-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRA-S Medication Solutions10bf69e7-5f7e-4448-9f22-777f137d96662023-12-25Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220
CefdinirCEFDINIRA-S Medication Solutionsa217d454-4ca0-4b29-8a64-eb9393a852692023-11-21Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210220
application number: ANDA210220

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
200346cefdinir 300 MG Oral CapsulePSNa0934baf-4745-4546-a63a-d4a660a188b31
200346cefdinir 300 MG Oral CapsuleSCDa0934baf-4745-4546-a63a-d4a660a188b31

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0904-7563-04009047563043 BLISTER PACK in 1 CARTON (0904-7563-04) / 10 CAPSULE in 1 BLISTER PACK3 blister pack2025-10-27NoNoCurrent